To work according to high ethical standards has always been part of BIAL’s DNA.
Only in this way can we earn the trust and respect of the healthcare professionals, patients and of the society in general, having as our pillars the quality, safety and efficacy of the products we commercialize.
BIAL’s Code of Conduct has been elaborated to highlight the ethical principles that govern BIAL and the relationships with all our partners.
Code of ethics and conduct
Anti-Bribery and Anti-Corruption Policy
What is the EFPIA Disclosure Code?
The EFPIA Disclosure Code is a code of conduct that requires all EFPIA member companies and companies that are members of EFPIA member associations to disclose transfers of value to HCPs and healthcare organisations (HCOs). Under the Code, EFPIA member companies, such as BIAL, will have to disclose the names of healthcare professionals and organisations that have received payments or other transfers of value from them.
EFPIA Disclosure Code – Signed Self-Certification
2016 2017 2018 2019 2020 2021 2022
In recognition of BIAL’s commitment to research and development, the group is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the respected federation of leading research firms in the European pharmaceutical sector.
We at BIAL, and according to our Transparency policy, confirm that our disclosures of transfers of value to HCPs and HCOs have been reported in line with the EFPIA Code of Practice key principles and its local transpositions.
Disclosure by country
Italy Germany Portugal Spain
UK - Disclosure Information 20220
UK - Disclosure Information 2021
UK - Methodological Note 2020
UK - Methodological Note 2021
Switzerland - Disclosure Information 2020
Switzerland - Disclosure Information 2021
BIAL takes responsibility for its website contents. By clicking “continue” below, you will be taken to an external website, beyond our responsibility.